Ignite Creation Date:
2024-05-06 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05722418
Status:
RECRUITING
Last Update Posted:
2024-05-06
First Post:
2022-12-19
Brief Title:
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With RelapsedRefractory Multiple Myeloma
Sponsor:
Caribou Biosciences Inc
Organization:
Caribou Biosciences Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-06
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-02
Completion Date Type:
ESTIMATED
First Submit Date:
2022-12-19
First Submit QC Date:
February 2 2023
Study First Post Date:
2023-02-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-03
Last Update Post Date:
2024-05-06
Last Update Post Date Type:
ACTUAL